Investors/Media

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events and Presentations

September 12, 2023 at 3:30 PM EDT
H.C. Wainwright 25th Annual Global Investment Conference Sign up
May 17, 2023 at 3:05 PM EDT
2023 RBC Capital Markets Global Healthcare Conference Sign up
May 15, 2023 at 1:30 PM EDT
The JMP Securities Life Sciences Conference Sign up